Venture CapitalSun Icon Ventures
StagesSeed, Pre-Series A
SectorsAI / ML, SaaS / Enterprise, Fintech · Early-stage builders, Founder-led / operator capital
Ticket$30K – $400K
Venture CapitalBeyond Next Ventures backs science and technology-driven startups at Pre-Seed through Series A, with a focus on DeepTech, HealthTech, AgriTech, CleanTech, and SpaceTech founders building high-impact, defensible businesses in India.
Key signals founders use to decide if this investor is worth a conversation.
Stages and sectors this investor typically backs.
Themes this investor is mapped to across the VC Dekho directory.
Beyond Next Ventures backs science and technology-driven startups at Pre-Seed through Series A, with a focus on DeepTech, HealthTech, AgriTech, CleanTech, and SpaceTech founders building high-impact, defensible businesses in India.
40 companies mapped to this fund.
Background and context for founders evaluating this investor.
Beyond Next Ventures operates a dedicated India investment platform as an extension of its Japan-headquartered venture practice, giving it a distinctive cross-border angle that few India-focused early-stage VCs can match. The firm writes cheques ranging from approximately $200,000 to $2,500,000, covering Pre-Seed through Series A, which means it can lead or participate at the earliest formation stages and follow on as companies gain traction. The sectoral focus spans DeepTech, HealthTech, AgriTech, CleanTech, SpaceTech, and Enterprise SaaS, with a clear preference for startups where science, proprietary technology, or hard IP forms the core of the business. Founders in regulated or capital-intensive domains such as diagnostics, biotech, precision agriculture, or space applications will find the team genuinely conversant with the technical and commercial nuances of these markets. Beyond Next Ventures also brings value beyond capital through its Japan network, which is particularly relevant for startups exploring manufacturing partnerships, regulatory approvals, or enterprise sales in the Japanese market. The portfolio signals an appetite for both B2B and B2C models as long as the technology differentiation is meaningful and the societal impact is visible.
The firm writes cheques ranging from approximately $200,000 to $2,500,000, covering Pre-Seed through Series A, which means it can lead or participate at the earliest formation stages and follow on as companies gain traction.
MediBuddy, BigHaat, Gig India, Medfin, Gromo, MUSE Diagnostics, ImpactGuru, Myelin Foundry, Faunatech, Lil Goodness, Biomoneta, Generic Aadhaar
We're interested in deep-tech startups solving important social and environmental challenges. We're also keen to assess startups powering digital transformation of industries.
Data confidence: Unverified – inferred
Partners and principals mapped to this fund in the directory.
Other funds that overlap on stage, sector, or thesis.
Jump into stage, sector, and thesis mapped to this fund.